Ferrari M C, Parini R, Di Rocco M D, Radetti G, Beck-Peccoz P, Persani L
Institute of Endocrine Sciences, University of Milan, Istituto Auxologico Italiano IRCCS and Ospedale Maggiore IRCCS, Milan, Italy.
Eur J Endocrinol. 2001 Apr;144(4):409-16. doi: 10.1530/eje.0.1440409.
The congenital disorders of glycosylation (CDGs) are progressive multisystemic disorders characterized by a heterogeneous deficiency of the carbohydrate moieties in various structural and circulating glycoproteins, representing a natural model for glycoprotein hormone studies. Here, we studied the carbohydrate moiety of circulating glycoprotein hormones in four patients with a clinical suspicion of CDGs.
The diagnosis of CDG-I was confirmed in two out of the four cases by transferrin isoelectrofocusing (IEF) and/or carbohydrate-deficient transferrin (CDT) test. The carbohydrate moiety of serum endocrine-related glycoproteins was investigated by means of Ricin (immunopurified thyrotropin (TSH)) and Concanavalin A (Con-A) (TSH, follicle-stimulating hormone, alpha-subunit and thyroglobulin) lectin affinity chromatography measurement.
CDT concentrations were very high in the two patients with CDG-I and moderately enhanced in the remaining two. In the two CDG-I patients, Ricin analysis of immunopurified TSH showed a severe impairment of lectin binding, both before and after neuroaminidase treatment, indicating a nearly complete lack of terminal sialic acid and galactose residues. In these two cases, Con-A analysis showed a significant prevalence of firmly bound isoforms with poorly processed carbohydrate chains. In the remaining two cases with unknown CDG classification, TSH binding pattern to Ricin was modestly affected and Con-A analysis showed the prevalence of weakly bound glycoprotein isoforms.
The results of Ricin analyses in all four patients were consistent with the CDT test and/or serum transferrin IEF. The severe alteration of TSH binding pattern to Ricin seems to be characteristic of CDG-I. Nevertheless, TSH biological properties are not severely altered, as normal thyroid function was found in both cases.
糖基化先天性疾病(CDGs)是进行性多系统疾病,其特征为各种结构和循环糖蛋白中碳水化合物部分存在异质性缺乏,是糖蛋白激素研究的天然模型。在此,我们研究了四名临床疑似患有CDGs患者循环糖蛋白激素的碳水化合物部分。
通过转铁蛋白等电聚焦(IEF)和/或缺糖转铁蛋白(CDT)检测,在四例患者中的两例确诊为I型CDG。通过蓖麻毒素(免疫纯化促甲状腺激素(TSH))和刀豆球蛋白A(Con - A)(TSH、促卵泡激素、α亚基和甲状腺球蛋白)凝集素亲和色谱测量法,研究血清内分泌相关糖蛋白的碳水化合物部分。
两名I型CDG患者的CDT浓度非常高,其余两名患者中度升高。在两名I型CDG患者中,对免疫纯化的TSH进行蓖麻毒素分析显示,在神经氨酸酶处理前后,凝集素结合均严重受损,表明几乎完全缺乏末端唾液酸和半乳糖残基。在这两例中,Con - A分析显示,碳水化合物链加工不良的紧密结合异构体占显著优势。在其余两例CDG分类不明的病例中,TSH与蓖麻毒素的结合模式受到轻度影响,Con - A分析显示弱结合糖蛋白异构体占优势。
所有四名患者的蓖麻毒素分析结果与CDT检测和/或血清转铁蛋白IEF一致。TSH与蓖麻毒素结合模式的严重改变似乎是I型CDG的特征。然而,由于两例患者甲状腺功能均正常,TSH的生物学特性并未严重改变。